Shareholders' most significant victory came May 19, when they voted to reject pharmaceutical multinational GlaxoSmithKline's salary offer to its chief executive, Jean-Pierre Garnier. Anger was fueled in large part by a $35.7-million golden parachute Garnier would collect from what is Britain's third-largest company should he be fired.